The U.S. Food and Drug Administration issued a marketing denial order for blu Disposable Classic Tobacco 2.4%, an e-cigarette product manufactured by Fontem US, the agency announced. “This means the company still must not market or distribute this product in the United States, or they risk enforcement action by FDA. The company may submit a new application for the product subject to this MDO,” the FDA stated. Publicly traded companies in the tobacco products space include Altria Group (MO), British American Tobacco (BTI), Imperial Brands (IMBBY) and Philip Morris (PM).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTI:
- Cautious Outlook on British American Tobacco Amid Market Challenges and Preference for Imperial Brands
- British American Tobacco price target raised to $40 from $35.50 at Morgan Stanley
- British American Tobacco price target raised to 3,300 GBp from 2,800 GBp at JPMorgan
- British American Tobacco price target raised to 4,450 GBp at Citi
- British American Tobacco price target raised to 4,400 GBp from 4,200 GBp at Deutsche Bank